Mark J. DiNubile
Io Therapeutics (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, Viral gastroenteritis research and epidemiology, Antifungal resistance and susceptibility, Antimicrobial Resistance in Staphylococcus
Most-Cited Works
- → Boceprevir for Untreated Chronic HCV Genotype 1 Infection(2011)2,497 cited
- → Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine(2006)1,877 cited
- → Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation(2017)1,163 cited
- → Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection(2008)683 cited
- → Amphotericin B Lipid Complex for Invasive Fungal Infections: Analysis of Safety and Efficacy in 556 Cases(1998)624 cited
- → Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial(2009)619 cited